BARSANTI PAUL A,HU CHENG,JIN JEFF,KEYES ROBERT,KUCEJKO ROBERT,LIN XIAODONG,PAN YUE,PFISTER KEITH B.,SENDZIK MARTIN,SUTTON JAMES,WAN LIFENG
申请号:
TN2011000644
公开号:
TN2011000644A1
申请日:
2011.12.15
申请国别(地区):
TN
年份:
2013
代理人:
摘要:
The present invention provides a compound of formula (I), and pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. Also provided is a method of treating a diseease or condition mediated by CDK9.